Statistics
Publications
25
Citations
1.8K
H-Index
19
Active since
2014
Jonathan D. Douros is an author at Novo Nordisk (United States) specializing in endocrinology, metabolic regulation, and life sciences.
Publications per year
2014–2025
25
25
Tirzepatide is an imbalanced and biased dual GIP and GLP-1 receptor agonist
Francis S. Willard, Jonathan D. Douros, M Gabe et al. · JCI Insight · 2020 · 487 citations · Full text
1–5 of 25